Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Preleukemia 1 Ovarian Neoplasms 1 Osteochondroma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Nevus, Epithelioid and Spindle Cell 1 Myelodysplastic Syndromes 1 Malnutrition 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Giant Cell Tumors 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Merkel Cell 1 Carcinoma, Lobular 1 Carcinoma in Situ 1 Barrett Esophagus 1

Interventions

pembrolizumab 29 avelumab 21 Nivolumab 20 Ipilimumab 10 Radiotherapy 9 Cyclophosphamide 9 atezolizumab 8 cemiplimab 7 fludarabine 6 Specimen Handling 6 durvalumab 5 aldesleukin 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Interleukin-2 5 Biopsy 5 talimogene laherparepvec 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Etoposide 3 Cisplatin 3 Carboplatin 3 CTLA-4 Antigen 3 Bevacizumab 3 prednylidene 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 deltacortene 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Sampling Studies × Clear all

NCT04705389 2021-05-18

SUMMERTIME

University Hospital, Tours

Phase NA Unknown

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡